8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) August 13, 2008

ICU Medical, Inc.
(Exact name of registrant as specified in its charter)

DELAWARE	0-19974	33-0022692
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

951 Calle Amanecer, San Clemente, California	92673
(Address of principal executive offices)	(Zip Code)

(949) 366-2183
Registrant's telephone number, including area code

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
	[   ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	[   ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
	[   ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
	[   ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01. Other Events.

On August 7, 2008, ICU Medical, Inc. entered an agreement with Premier, Inc., under which ICU will offer Premier its complete line of needleless I.V. system connectors, its valued custom I.V. system program and its new line of "Safe Handling" products designed to provide a complete range of environmental improvement and safety for the use of oncology and other drugs. See attached press release.

Item 9.01. Financial Statements and Exhibits.

(c)	Exhibits
99.1	Press release, dated August 13, 2008 announcing that ICU Medical, Inc. entered an agreement with Premier, Inc.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ICU Medical, Inc.
Date: August 13, 2008	/s/ SCOTT E. LAMB Scott E. Lamb Secretary, Treasurer and Chief Financial Officer

EX-99.1

EXHIBIT 99.1

ICU Medical, Inc. Enters First-Ever Agreement With Leading Healthcare Purchasing Network, Premier, Inc.

New Agreement Expands ICU Medical's Potential North American Distribution by 40% Through 2,000 Additional Hospitals and Over 50,000 Alternative Healthcare Sites

SAN CLEMENTE, Calif., Aug. 13, 2008 (PRIME NEWSWIRE) -- ICU Medical, Inc., (Nasdaq:ICUI), a leading low cost manufacturer of safe medical connectors, custom medical products and critical care devices, on August 7, 2008, entered into a five-year agreement with Premier, Inc., operator of one of the nation's largest healthcare purchasing networks.

Under the terms of the agreement, ICU Medical will offer Premier its complete line of market leading CLAVE and MicroClave needleless I.V. systems, its valued custom I.V. Set program, and ICU's line of "Safe Handling" oncology products. This new line of oncology products is the only system which protects healthcare providers, patients, and the environment from exposure and complications related to exposure throughout the whole oncology drug therapy process.

About Premier, Inc.

Premier, Inc. is a 2006 Malcolm Baldrige National Quality Award recipient. Serving more than 2,000 U.S. hospitals and over 50,000 other healthcare sites, the Premier healthcare alliance and its members are transforming healthcare together. Owned by not-for-profit hospitals, Premier operates one of the leading healthcare purchasing networks and the nation's most comprehensive repository of hospital clinical and financial information. A world leader in helping healthcare providers deliver dramatic improvements in care, Premier is working with the United Kingdom's National Health Service North West and the Centers for Medicare and Medicaid Services to improve hospital performance. Headquartered in San Diego, Premier has offices in Charlotte, N.C., Philadelphia and Washington. For more information, visit www.premierinc.com.

About ICU Medical, Inc.

ICU Medical, Inc. (Nasdaq:ICUI) is a leader in the development, manufacture and sale of proprietary, disposable medical connection systems for use in vascular therapy applications. Our devices are designed to protect patients from catheter related bloodstream infections and healthcare workers from exposure to infectious diseases through accidental needle sticks. We are also a leader in the production of custom I.V. systems and we incorporate our proprietary products into many of those custom I.V. systems. For more information, visit www.icumed.com.

The foregoing statement concerning Management's expectation with respect to future results is a forward-looking statement based upon the best information currently available to Management and assumptions Management believes are reasonable, but Management does not intend the statement to be a representation as to future results. Future results are subject to risks and uncertainties, including the risk factors described in the Company's filings with the Securities and Exchange Commission, which include those in the Form 10-K for the year ended December 31, 2007 and 10Q for the quarter ended June 30, 2008. Actual results in the future may differ materially from Management's current expectations.

CONTACT:  ICU Medical, Inc.
          Scott Lamb, Chief Financial Officer
          (949) 366-2183

          ICR, Inc.
          John F. Mills, Senior Managing Director
          (310) 954-1100